Book contents
- Movement Disorders and Inherited Metabolic Disorders
- Movement Disorders and Inherited Metabolic Disorders
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Acknowledgments
- Section I General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Section II A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Chapter 12 Disorders of Amino Acid Metabolism: Amino Acid Disorders, Organic Acidurias, and Urea Cycle Disorders with Movement Disorders
- Chapter 13 Disorders of Energy Metabolism: GLUT1 Deficiency Syndrome and Movement Disorders
- Chapter 14 Lysosomal Storage Disorders: Niemann–Pick Disease Type C and Movement Disorders
- Chapter 15 Lysosomal Storage Disorders: Neuronal Ceroid Lipofuscinoses and Movement Disorders
- Chapter 16 Syndromes of Neurodegeneration with Brain Iron Accumulation
- Chapter 17 Metal Storage Disorders: Inherited Disorders of Copper and Manganese Metabolism and Movement Disorders
- Chapter 18 Metal Storage Disorders: Primary Familial Brain Calcification and Movement Disorders
- Chapter 19 Disorders of Glycosylation and Movement Disorders
- Chapter 20 Disorders of Post-Translational Modifications/Degradation: Autophagy and Movement Disorders
- Chapter 21 Neurotransmitter Disorders: Disorders of Dopamine Metabolism and Movement Disorders
- Chapter 22 Neurotransmitter Disorders: DNAJC12-Deficient Hyperphenylalaninemia – An Emerging Neurotransmitter Disorder
- Chapter 23 Neurotransmitter Disorders: Disorders of GABA Metabolism and Movement Disorders
- Chapter 24 Vitamin-Responsive Disorders: Ataxia with Vitamin E Deficiency and Movement Disorders
- Chapter 25 Vitamin-Responsive Disorders: Biotin–Thiamine-Responsive Basal Ganglia Disease and Movement Disorders
- Chapter 26 Disorders of Cholesterol Metabolism: Cerebrotendinous Xanthomatosis and Movement Disorders
- Chapter 27 Purine Metabolism Defects: The Movement Disorder of Lesch–Nyhan Disease
- Chapter 28 Disorders of Creatine Metabolism: Creatine Deficiency Syndromes and Movement Disorders
- Chapter 29 Hereditary Spastic Paraplegia-Related Inborn Errors of Metabolism
- Section III Conclusions and Future Directions
- Appendix: Video Captions
- Index
- References
Chapter 20 - Disorders of Post-Translational Modifications/Degradation: Autophagy and Movement Disorders
from Section II - A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders
Published online by Cambridge University Press: 24 September 2020
Book contents
- Movement Disorders and Inherited Metabolic Disorders
- Movement Disorders and Inherited Metabolic Disorders
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Acknowledgments
- Section I General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Section II A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Chapter 12 Disorders of Amino Acid Metabolism: Amino Acid Disorders, Organic Acidurias, and Urea Cycle Disorders with Movement Disorders
- Chapter 13 Disorders of Energy Metabolism: GLUT1 Deficiency Syndrome and Movement Disorders
- Chapter 14 Lysosomal Storage Disorders: Niemann–Pick Disease Type C and Movement Disorders
- Chapter 15 Lysosomal Storage Disorders: Neuronal Ceroid Lipofuscinoses and Movement Disorders
- Chapter 16 Syndromes of Neurodegeneration with Brain Iron Accumulation
- Chapter 17 Metal Storage Disorders: Inherited Disorders of Copper and Manganese Metabolism and Movement Disorders
- Chapter 18 Metal Storage Disorders: Primary Familial Brain Calcification and Movement Disorders
- Chapter 19 Disorders of Glycosylation and Movement Disorders
- Chapter 20 Disorders of Post-Translational Modifications/Degradation: Autophagy and Movement Disorders
- Chapter 21 Neurotransmitter Disorders: Disorders of Dopamine Metabolism and Movement Disorders
- Chapter 22 Neurotransmitter Disorders: DNAJC12-Deficient Hyperphenylalaninemia – An Emerging Neurotransmitter Disorder
- Chapter 23 Neurotransmitter Disorders: Disorders of GABA Metabolism and Movement Disorders
- Chapter 24 Vitamin-Responsive Disorders: Ataxia with Vitamin E Deficiency and Movement Disorders
- Chapter 25 Vitamin-Responsive Disorders: Biotin–Thiamine-Responsive Basal Ganglia Disease and Movement Disorders
- Chapter 26 Disorders of Cholesterol Metabolism: Cerebrotendinous Xanthomatosis and Movement Disorders
- Chapter 27 Purine Metabolism Defects: The Movement Disorder of Lesch–Nyhan Disease
- Chapter 28 Disorders of Creatine Metabolism: Creatine Deficiency Syndromes and Movement Disorders
- Chapter 29 Hereditary Spastic Paraplegia-Related Inborn Errors of Metabolism
- Section III Conclusions and Future Directions
- Appendix: Video Captions
- Index
- References
Summary
Autophagy is a term derived from the Ancient Greek word autóphagos, meaning “self-eating” or “self-devouring.” The term is used to describe a major cellular degradation process that ensures cellular quality control. By targeting dysfunctional cellular components and delivering them to the endosome–lysosome system for degradation, autophagy clears cells of cellular debris and recycles basic building blocks for de novo synthesis of cellular components.
- Type
- Chapter
- Information
- Movement Disorders and Inherited Metabolic DisordersRecognition, Understanding, Improving Outcomes, pp. 270 - 277Publisher: Cambridge University PressPrint publication year: 2020
References
Ebrahimi-Fakhari, D, Saffari, A, Wahlster, L, et al. Congenital disorders of autophagy: An emerging novel class of inborn errors of neuro-metabolism. Brain. 2016;139(Pt 2):317–37.CrossRefGoogle ScholarPubMed
Ebrahimi-Fakhari, D. Congenital disorders of autophagy: What a pediatric neurologist should know. Neuropediatrics. 2018;49(1):18–25.Google Scholar
Teinert, J, Behne, R, Wimmer, M, Ebrahimi-Fakhari, D. Novel insights into the clinical and molecular spectrum of congenital disorders of autophagy. J Inherit Metab Dis. 2019;doi:10.1002/jimd.12084.Google Scholar
Mizushima, N, Komatsu, M. Autophagy: Renovation of cells and tissues. Cell. 2011;147(4):728–41.Google Scholar
Choi, AM, Ryter, SW, Levine, B. Autophagy in human health and disease. N Engl J Med. 2013;368(19):1845–6.Google Scholar
Klionsky, DJ, Abdalla, FC, Abeliovich, H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8(4):445–544.Google Scholar
Hogarth, P. Neurodegeneration with brain iron accumulation: Diagnosis and management. J Mov Disord. 2015;8(1):1–13.CrossRefGoogle ScholarPubMed
Saitsu, H, Nishimura, T, Muramatsu, K, et al. De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet. 2013;45(4):445–9, 9e1.Google Scholar
Hayflick, SJ, Kruer, MC, Gregory, A, et al. Beta-propeller protein-associated neurodegeneration: A new X-linked dominant disorder with brain iron accumulation. Brain. 2013;136(Pt 6):1708–17.CrossRefGoogle ScholarPubMed
Gregory, A, Kurian, MA, Haack, T, Hayflick, SJ, Hogarth, P. Beta-propeller protein-associated neurodegeneration. GeneReviews®. 2017;Feb 16.Google Scholar
Haack, TB, Hogarth, P, Kruer, MC, et al. Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet. 2012;91(6):1144–9.Google Scholar
Behrends, C, Sowa, ME, Gygi, SP, Harper, JW. Network organization of the human autophagy system. Nature. 2010;466(7302):68–76.Google Scholar
Akizu, N, Cantagrel, V, Zaki, MS, et al. Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome–autophagosome dysfunction. Nat Genet. 2015;47(5):528–34.CrossRefGoogle Scholar
Thomas, AC, Williams, H, Seto-Salvia, N, et al. Mutations in SNX14 cause a distinctive autosomal-recessive cerebellar ataxia and intellectual disability syndrome. Am J Hum Genet. 2014;95(5):611–21.Google Scholar
Kim, M, Sandford, E, Gatica, D, et al. Mutation in ATG5 reduces autophagy and leads to ataxia with developmental delay. Elife. 2016;5.CrossRefGoogle Scholar
Haack, TB, Ignatius, E, Calvo-Garrido, J, et al. Absence of the autophagy adaptor SQSTM1/p62 causes childhood-onset neurodegeneration with ataxia, dystonia, and gaze palsy. Am J Hum Genet. 2016;99(3):735–43.Google Scholar
Salinas, S, Proukakis, C, Crosby, A, Warner, TT. Hereditary spastic paraplegia: Clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7(12):1127–38.CrossRefGoogle ScholarPubMed
Ashrafi, G, Schwarz, TL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013;20(1):31–42.Google Scholar
Pensato, V, Castellotti, B, Gellera, C, et al. Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain. 2014;137(Pt 7):1907–20.Google Scholar
Mallaret, M, Lagha-Boukbiza, O, Biskup, S, et al. SPG15: A cause of juvenile atypical levodopa responsive parkinsonism. J Neurol. 2014;261(2):435–7.Google Scholar
Pascual, B, de Bot, ST, Daniels, MR, et al. “Ears of the lynx” MRI sign is associated with SPG11 and SPG15 hereditary spastic paraplegia. AJNR Am J Neuroradiol. 2019;40(1):199–203.Google Scholar
Chang, J, Lee, S, Blackstone, C. Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation. J Clin Invest. 2014;124(12):5249–62.Google Scholar
Ebrahimi-Fakhari, D, Cheng, C, Dies, K, et al. Clinical and genetic characterization of AP4B1-associated SPG47. Am J Med Genet A. 2018;176(2):311–8.CrossRefGoogle ScholarPubMed
Oz-Levi, D, Ben-Zeev, B, Ruzzo, EK, et al. Mutation in TECPR2 reveals a role for autophagy in hereditary spastic paraparesis. Am J Hum Genet. 2012;91(6):1065–72.CrossRefGoogle ScholarPubMed
Anheim, M, Tranchant, C, Koenig, M. The autosomal recessive cerebellar ataxias. N Engl J Med. 2012;366(7):636–46.Google Scholar
Pickrell, AM, Youle, RJ. The roles of PINK1, Parkin, and mitochondrial fidelity in Parkinson’s disease. Neuron. 2015;85(2):257–73.CrossRefGoogle ScholarPubMed